AcouSort to present its unique acoustofluidics technology at the international conference µTAS 2023
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Pressmeddelande

AcouSort to present its unique acoustofluidics technology at the international conference µTAS 2023

AcouSort’s technology makes it possible to fractionate the different cell types in a blood sample, isolate extracellular vesicles, or wash cells to remove contaminants, without having any physical contact with the sample. The technology continues to find its way into an increasing number of life science applications. On October 15-19, 2023, AcouSort will attend µTAS 2023, the 27th International Conference on Miniaturized Systems for Chemistry and Life Sciences, to present the unique features of its technology.

The µTAS 2023 conference is expected to attract some 1,000 scientists and industry professionals and  focuses on microfluidics/lab-on-a-chip systems for life science applications. AcouSort’s presence at the conference will be dedicated to displaying its technology for the cell therapy market, an area which is of rapidly increasing interest for the Company. AcouSort’s technology will be presented in the exhibition area as well as in two separate poster presentations:

  • One poster is presented by Senior Scientist Mikael Evander and addresses the use of AcouTrap technology to isolate and wash stem cells before they are used in therapy
  • The other poster is presented by AcouSort’s NIH customer Dr Stephen Adler and addresses the use of the AcouWash technology for centrifuge-free radiolabeling of immune cells in cancer treatment

Both poster presentations are related to the use of AcouSort’s technology in different cell therapy applications. In conjunction with the conference, AcouSort will also release a new application note on the new high-throughput acoustic separation solution for automated processing in cell therapy manufacturing. 

“µTAS 2023 is a perfect conference for us to present our unique technology. Over the past year or so, we have made a significant number of inroads into the cell therapy space. Our ambition now is to establish as many research collaborations as possible to pave the way for future OEM partnerships,” says Jessica Congiu, Commercial Product Manager at AcouSort.

Bifogade filer

Nyheter om AcouSort

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!

STÄNG X
Populär sparapp – över 500 000 nedladdningar
Många och höga externa omdömen
Högst grad av diversifiering
Perfekt för regelbundet månadssparande
KOM IGÅNG

Nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 får automatiskt 50 procent rabatt på Optis avgift i 3 månader

Om aktien AcouSort

Senaste nytt